Abstract
Aims
Periostin (POSTN) is implicated in cancer development and progression. The aim of this study was to evaluate the diagnostic and prognostic significance of serum POSTN in patients with hepatocellular carcinoma (HCC) receiving curative surgery.Methods
Enzyme-linked immunosorbent assay was performed to determine serum POSTN levels in 69 healthy volunteers, 30 patients with hepatolithiasis, 27 patients with cirrhosis, and 56 HCC patients. The relationships between serum POSTN and clinicopathologic features were analyzed. Receiver operating characteristics analysis was used to calculate diagnostic accuracy of serum POSTN, serum alpha-fetoprotein (AFP), and their combination. The prognostic impact of serum POSTN on overall survival (OS) and relapse-free survival (RFS) was also investigated.Results
The median serum POSTN level was significantly (P < 0.05) increased in HCC patients, compared to healthy controls, patients with hepatolithiasis, and patients with liver cirrhosis. Elevated serum POSTN was only significantly associated with Edmondson grade (P = 0.007). The combination of serum POSTN and AFP had a markedly higher area under the curve (0.805 (95% confidence interval [CI]: 0.677-0.932)) than POSTN (0.582 (95% CI: 0.427-0.736)) or AFP (0.655 (95% CI: 0.504-0.806)) alone. Kaplan-Meier analysis indicated that elevated serum POSTN was associated with OS (P = 0.031) and RFS (P = 0.027). Moreover, multivariate analysis revealed elevated serum POSTN as an independent poor prognostic marker for OS and RFS.Conclusions
Preoperative serum POSTN has limited diagnostic value in distinguishing HCC from non-malignant liver diseases, but serves as independent prognostic biomarker in HCC patients.References
Articles referenced by this article (32)
The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.
Oncologist, 5-13 2010
MED: 21115576
Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Minerva Med, (5):363-371 2011
MED: 22193346
Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta
J Bone Miner Res 1999
Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I.
Biochem J, 271-278 1993
MED: 8363580
Beta ig-h3 mediates osteoblast adhesion and inhibits differentiation.
Bone, (2):232-242 2005
MED: 15780949
Stabilin-1 and stabilin-2 are both directed into the early endocytic pathway in hepatic sinusoidal endothelium via interactions with clathrin/AP-2, independent of ligand binding.
Exp Cell Res, (1):160-173 2005
MED: 15572036
Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway.
Cancer Cell, (4):329-339 2004
MED: 15093540
Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation
J Biol Chem 2006
Show 10 more references (10 of 32)
Citations & impact
Impact metrics
Citations of article over time
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/j.ejso.2013.06.023
Article citations
Current evidence regarding the cellular mechanisms associated with cancer progression due to cardiovascular diseases.
J Transl Med, 22(1):105, 26 Jan 2024
Cited by: 0 articles | PMID: 38279150 | PMCID: PMC10811855
Review Free full text in Europe PMC
Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer.
J Mol Med (Berl), 101(12):1603-1614, 13 Oct 2023
Cited by: 4 articles | PMID: 37831111
Association of Differentially Altered Liver Fibrosis with Deposition of TGFBi in Stabilin-Deficient Mice.
Int J Mol Sci, 24(13):10969, 30 Jun 2023
Cited by: 5 articles | PMID: 37446152 | PMCID: PMC10341388
Perioperative predictors of outcome of hepatectomy for HBV-related hepatocellular carcinoma.
Front Oncol, 13:1230164, 13 Jul 2023
Cited by: 1 article | PMID: 37519791 | PMCID: PMC10373594
Review Free full text in Europe PMC
Multiple Roles of LOXL2 in the Progression of Hepatocellular Carcinoma and Its Potential for Therapeutic Targeting.
Int J Mol Sci, 24(14):11745, 21 Jul 2023
Cited by: 2 articles | PMID: 37511503 | PMCID: PMC10380739
Review Free full text in Europe PMC
Go to all (37) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma.
Ann Surg Oncol, 20(3):929-937, 01 Dec 2012
Cited by: 14 articles | PMID: 23203407
Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.
Am J Gastroenterol, 101(9):2051-2059, 18 Jul 2006
Cited by: 82 articles | PMID: 16848813
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
Hepatology, 56(4):1371-1379, 01 Oct 2012
Cited by: 105 articles | PMID: 22535689
Funding
Funders who supported this work.
National Natural Science Foundation of China (1)
Grant ID: 81201906